Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...
A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
CHEROKEE COUNTY, Ga. — A Cherokee County man living with Sickle Cell Disease is now the first known person with the condition to get a medical pilot’s license. Channel 2’s Fred Blankenship spoke with ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United ...
INDIANAPOLIS (WISH) — For the first time, scientists say new therapies have the power to cure sickle cell disease. The disease is a devastating, inherited blood disorder that affects an estimated ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United ...
Chicago’s South Side residents now have access to a new sickle-cell treatment clinic at Roseland Community Hospital. On Monday, Roseland held a ribbon-cutting ceremony introducing Dr. Mahoud Mahafzah ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle ...
The MarketWatch News Department was not involved in the creation of this content. PRINCETON, NJ, Nov. 18, 2025 /CNW/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay ...
Please provide your email address to receive an email when new articles are posted on . Patients with sickle cell disease who have vaso-occlusive crises often get delayed treatment in ED due to ...